Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

Bill Gates, co-chair of the Bill and Melinda Gates Foundation, on Monday met Union Agriculture Minister Shivraj Singh Chouhan ...

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

On March 5, the US Court of Appeals for the Federal Circuit issued a decision in Lashify, Inc. v. International Trade Commission, No.

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

VC funding into AI tools for healthcare was projected to hit $11 billion last year -- a headline figure that speaks to the ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases.